These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 35615979)

  • 1. Knee osteoarthritis and the knowledgeable, trustworthy pharmacist: Patient and pharmacist perceptions of community pharmacy-based education and support.
    Darlow B; Brown M; Hudson B; Frew G; Clark J; Vincent L; Grainger R; Marra C; McKinlay E; Abbott JH; Briggs AM
    Musculoskeletal Care; 2023 Mar; 21(1):3-15. PubMed ID: 35615979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacist health coaching in Australian community pharmacies: What do pharmacy professionals think?
    Singh HK; Kennedy GA; Stupans I
    Health Soc Care Community; 2020 Jul; 28(4):1190-1198. PubMed ID: 32020737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacist peer coaching in a traditional community chain pharmacy: Implementation and perceptions.
    Hake KL; Carroll JC; Somma McGivney MA; Coley KC
    J Am Pharm Assoc (2003); 2021; 61(4S):S85-S90. PubMed ID: 33781696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Qualitative exploration of the experiences of community pharmacists delivering the Diabetes MedsCheck service.
    Gargya D; Mirkazemi C; Curtain C
    J Clin Pharm Ther; 2022 Aug; 47(8):1194-1200. PubMed ID: 35322454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Examining the association between the "My Pharmacist" model and the service quality of community pharmacies.
    Goto K; Sato T; Shikamura Y; Nomura K; Negishi K; Hanawa T
    Res Social Adm Pharm; 2020 Jul; 16(7):958-966. PubMed ID: 31839583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of pharmacy and pharmacist characteristics on the secondary prevention of cardiovascular disease.
    Puspitasari HP; Aslani P; Krass I
    Int J Clin Pharm; 2015 Oct; 37(5):834-43. PubMed ID: 25964140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of hypertension in an Australian community pharmacy setting - patients' beliefs and perspectives.
    Bajorek BV; LeMay KS; Magin PJ; Roberts C; Krass I; Armour CL
    Int J Pharm Pract; 2017 Aug; 25(4):263-273. PubMed ID: 27633151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacist views and pharmacy capacity to deliver professional services in the United Arab Emirates.
    Alzubaidi H; Saidawi W; Mc Namara K
    Int J Clin Pharm; 2018 Oct; 40(5):1106-1115. PubMed ID: 29926256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacist and physician perspectives on diabetes service delivery within community pharmacies in Indonesia: a qualitative study.
    Wibowo Y; Sunderland B; Hughes J
    Int J Pharm Pract; 2016 May; 24(3):180-8. PubMed ID: 26670327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation of comprehensive medication management at supermarket pharmacies in a pharmacy network.
    Doong K; Berenbrok LA; Coley KC; Carroll JC; Richardson R; Antinopoulos BC; Patel A; McGivney MS
    J Am Pharm Assoc (2003); 2019; 59(4S):S25-S31. PubMed ID: 31080149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors influencing patient participation in medication counseling at the community pharmacy: A systematic review.
    Qudah B; Thakur T; Chewning B
    Res Social Adm Pharm; 2021 Nov; 17(11):1863-1876. PubMed ID: 33766505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perspectives on an amended law addressing pharmacists' availability in community pharmacies.
    Qadeer G; Amin MEK
    J Eval Clin Pract; 2021 Feb; 27(1):151-157. PubMed ID: 32319720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful implementation and provision of enhanced and extended pharmacy services.
    Hattingh L; Sim TF; Sunderland B; Czarniak P
    Res Social Adm Pharm; 2020 Apr; 16(4):464-474. PubMed ID: 31272922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient and prescriber perceptions of depression screening within a community pharmacy setting.
    Mospan CM; Gillette C; Wilson JA
    J Am Pharm Assoc (2003); 2020; 60(5S):S15-S22. PubMed ID: 32280022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Community pharmacists' educational needs for implementing clinical pharmacogenomic services.
    Berenbrok LA; Hart KM; McGrath SH; Coley KC; Somma McGivney MA; Empey PE
    J Am Pharm Assoc (2003); 2019; 59(4):539-544. PubMed ID: 31010787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Community pharmacists' perceptions of services that benefit older people in New Zealand.
    Tordoff J; Chang SY; Norris PT
    Int J Clin Pharm; 2012 Apr; 34(2):342-50. PubMed ID: 22328011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacists experience of and perspectives about recruiting patients into a community pharmacy asthma service trial.
    Bertilsson E; Serhal S; Emmerton L; Bosnic-Anticevich S; Krass I; Bereznicki B; Bereznicki L; Armour C; Saini B
    Res Social Adm Pharm; 2021 Mar; 17(3):595-605. PubMed ID: 32448767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Community pharmacists' prescription intervention practices--exploring variations in practice in Norwegian pharmacies.
    Mandt I; Horn AM; Ekedahl A; Granas AG
    Res Social Adm Pharm; 2010 Mar; 6(1):6-17. PubMed ID: 20188324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enablers and challenges to pharmacy practice change in Kuwait hospitals: a qualitative exploration of pharmacists' perceptions.
    Katoue MG
    J Eval Clin Pract; 2021 Apr; 27(2):272-279. PubMed ID: 32929812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Community pharmacist-led clinical services: physician's understanding, perceptions and readiness to collaborate in a Midwestern state in the United States.
    Gordon C; Unni E; Montuoro J; Ogborn DB
    Int J Pharm Pract; 2018 Oct; 26(5):407-413. PubMed ID: 29218803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.